Since the first emergence of the novel coronavirus in December 2019 in Wuhan, China, and the subsequent pandemic, the disease has become a major matter of concern for global health and affected millions of people all over the world. SARS coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, targets the upper and lower respiratory tracts in most cases. Their involvement would cause pneumonia with symptoms such as dry cough, dyspnea, fever, sputum production, and rhinorrhea. 1 One of the significant complications related to this virus is the ability of the disease to affect other organs with a wide range of signs and symptoms. Gastrointestinal manifestations (e.g., nausea, vomiting, diarrhea, anorexia, etc.), neurological manifestations (e.g., anosmia, ageusia, headache, altered mental status, dizziness, etc.), and multiorgan dysfunction (e.g., metabolic or electrolyte imbalance, etc.) may occur in COVID-19 patients. 2 In this case presentation, we aim to focus on the cardiovascular complications of COVID-19. They can present in different forms and severities, from nonspecific palpitations and chest tightness to life-threatening events such as left ventricular dysfunction (heart failure), acute